An employee of the Egyptian pharmaceutical company Eva Pharma has a package containing vials of Remdesivir, a broad-spectrum antiviral drug approved as a specific treatment for COVID-19, at the company’s factory, which started producing the drug this week with a production capacity of up to 1.5 million doses per month. …
Read More »Mylan quotes his generic remdesivir in India at $ 64 per 100 mg vial
